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ABSTRACT  
The Purpose of designing sustained or controlled delivery systems has always been to bring down the dose frequency that 
offers better patient compliance & reduced side effects Microspheres have shown to reduce the dose, side effects, frequency of 
administration and possibility of dose dumping, therefore increased patient compliance. There are several methods of 
preparation for microspheres, slight variation in basic method can produce numerous changes in final outcome. However 
various problems are still not resolved with these methods like wide size distribution & poor repeatability. Biodegradation rate 
of the microspheres in controlled by the composition of the microspheres and consecutively affects the release profile of drug, 
i.e. PGA, PLA and PCL have hydrolytic degradation role in order of PGA>PLA>>PCL.  
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The purpose of designing sustained or controlled delivery 
systems has always been to improve pharmacokinetic 
profile of a drug candidate viz. extended half-life, improved 
bioavailability with reduction in dosing frequency. In 
addition, this system also offers target site delivery, better 
patient compliance, reduces frequency and severity 
particularly in the case of cytotoxic drugs where one intends 
to achieve only local or target specific action(1). Among many 
available drug delivery systems for sustained release of the 
drug microspheres is gaining world-wide popularity due to 
high efficiency and better compatibility. Biodegradable 
polymers have been approved by US FDA and are widely 
employed in surgical sutures, implantable devices and in 
drug delivery systems. Microspheres as delivery systems 
have shown improved outcome via alteration of release 
profile of various drugs, proteins and genes.  
Microspheres have now been considered as reliable and 
effective release system which reduces dose, dosing 
frequency,   and possibility of dose dumping with high 
patient compliance (2). Microspheres prepared by innate or 
artificial polymers provides sustained release, for instance  
polyesters used in microspheres, have the  benefit  of  using 
water as  a vehicle to  form  suspensions which  offers 
constant release of desired   drug.  It has been documented 
that release of a drug from microsphere is directly 
influenced with certain factors viz. physicochemical 
properties of a drug, primary burst and excipients3. 
Injectable microsphere systems were developed in late 70’s. 
Poly (lactide) and/or poly (lactide-co-glycolide) was used to 
encapsulate an ester of norethisteron called NET via oil-in-
water emulsion/solvent evaporation process. These 
microcrystals of NET were encapsulated into microspheres 
of PLA and PLGA. Since then PLGA has been the first choice 
of polymer for preparation of microspheres to encapsulate 
APIs using w/o or o/w emulsion/solvent evaporation 
technique. Poly (ε-caprolactone) is the secondly most 
accepted polymer for preparation of microspheres to 
encapsulate APIs. Moreover   PLGA, PCL and PLA, diblock 
copolymers of lactide, ethylene glycol, L-lactide and ε-
caprolactone, triblock co polymers of caprolactons, lactides 
and glycolides, have also  been  used  to  encapsulate  APIs  
via  o/w emulsion / solvent evaporation. (3) 
Biodegradation rate of the microspheres is directly linked to 
its composition which in turn affects the release profiles of 
API. For instance as PGA, PLA and PCL have hydrolytic 
degradation rate in order of PGA > PLA >> PCL. PCL have 
excellent permeability in case of steroidal drugs but it shows 
slow biodegradation, in contrast, PLA and PGA had inferior 
permeability in case of steroidal drugs but it shows 
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homogenous biodegradation. It has been observed that 
microspheres of PLGA get degraded quicker and release of 
API is more rapid from the microspheres when hydrophilic 
glycolide component is increased in the system.  The 
polymer’s chirality, density of cross linking and loading of 
drugs in microspheres also influences the release profiles of 
API. Casein and chitosan microspheres shows slower release 
of API particularly when the amount of cross linking is 
increases significantly as it results in increased barrier 
density for drug diffusion, with reduction in the drug 
loading. Higher initial burst in microspheres has been 
observed when un-encapsulated drug is available in higher 
quantity on the surface of microspheres. (3) 
The microsphere’s size can be determined by   the ratio of 
surface area to volume which gives an idea about the 
amount of surface accessible for releasing the APIs in the 
course of diffusion. Microspheres which are small in size, 
have higher ratio of surface area to volume and lesser 
diffusion path length and thus provides better API release 
and shorter duration. Microsphere’s size inversely affects 
the effectiveness of the injectability, the bigger the size is, 
the more difficult they are to inject via needles. The Most 
favorable size range for effectiveness of injection is between 
20 and 90 μm. Concentration of polymers used for 
fabricating the microspheres have regulates the average size 
of microspheres. More the concentration of polymer is, 
higher is the organic phase viscosity in emulsion droplet and 
therefore the larger the average size    which allow   higher 
amount of APIs   encapsulation into the microspheres. An 
additional important feature affecting release of API is 
molecular weight (MW) of the polymers used in construction 
of microspheres. (3) 
SELECTION OF METHOD OF PREPARATION OF 
MICROSPHERES 
According to literature there are several methods of 
preparation for microspheres. In some cases, slight variation 
in basic methods is also reported. These variations in basic 
methods can produce numerous changes in final outcome. 
However, some of the basic techniques for microsphere 
preparation has been gathered from literature survey and 
are listed below 
Interfacial Polymerization Technique (4) 
In this technique, two types of monomers are one is water 
soluble and the other monomer is oil soluble. These two 
monomers form a polymer on droplet surface. This method 
provides wide range of products to be encapsulated such as 
water immiscible liquids, solids and aqueous solutions. 
However, this technique is mostly used for encapsulation of 
liquids in comparison to other products because 
polymerization is easily achieved when a liquid is used 
rather than a solid. There are few limitations or 
disadvantages of this process such as 
 Reaction between active substance and reagents. 
 Alteration in solubility of active substance 
 Toxicity produced due to untreated monomers 
 Degradation resulted by monomer reactions 
High permeability of coating and fragility of microspheres 
This technique can produce different type of microspheres 
such as microspheres having semi permeable or non 
permeable lipid membranes with aqueous core or release 
controlling coating with a solid core some of which are 
mention below 
Water immiscible liquid core 
 In this monomer is dissolved in liquid water immiscible 
core. Normally used monomers in this scenario are 
isocynate, acid chloride or some combination of both. A 
dispersing agent and a coreactant which is dispersed in an 
aqueous phase are used. Monomer solution is then added to 
this aqueous phase which results in polymerization at 
interface. 
Water miscible liquid core 
Water in oil emulsion is formed with the help of an 
emulsifier when a solution of a hydrophilic liquid, is mixed 
in an oily phase. When reactant which is not soluble in water 
is added to this w/o emulsion, on the surface of liquid 
droplets a polymer membrane is created.  
Solid core 
In this method, polymerization takes place spontaneously on 
solid surface. Solid core can be generated by vinyl monomer 
which helps in encapsulation and polymerization. 
Coacervation/ Phase Separation Technique (5) 
Dutch scientist, Bungenburg de jong and Kruyt used term 
coacervation for the first time to describe the phase 
separation phenomenon in colloidal system. They observed 
that this phase separation or coacervation was the result of 
precipitation or flocculation of the colloidal material from 
solution and this coacervation occurred just before 
precipitation from solution. The term coacervate is 
constituted with amorphous liquid droplets of separated 
phase which is rich in colloids. 
This coacervate is deposited around individual minute 
insoluble particles mixed in liquid which forms embryonic 
capsules. Appropriate gelling of this left coacervate 
consequences in nanoencapsulation. This method is 
subdivided into following types 
Aqueous Phase Separation  
Only hydrophobic materials both in solid and liquid solid 
form can be encapsulated by this technique. In this process a 
wall material which is polymeric, is mixed in water and the 
water insoluble core material is mixed in above water phase. 
Encapsulation occurs when the nucleus material is 
precipitated and encases the hydrophobic nucleus material 
after adding of precipitating agent or decreased temperature 
or change of pH. This aqueous phase separation technique is 
also subdivided in to two types: 
Simple Coacervation  
It can be achieved by the adding of a highly hydrophilic 
agent in the system e.g. alcohols and salts.  The core material 
is dispersed in aqueous polymeric solution, in which 
insufficiency of water for hydrophilic colloid results 
deposition of coacervate around the core and transformed 
into gel and nanocapsule hardened Coacervates. 
Complex Coacervation 
This process primarily depends on pH and involves 
neutralization of the charges of colloids. This is achieved by 
mixing two oppositely charged colloids together. This can be 
summarized in following steps: 
 A hydrophilic colloid solution is prepared 
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 A second hydrophilic colloid solution is added to first 
hydrophilic colloid solution to induce coacervation 
 Deposition occurs around the core 
 Coacervates appears as gel and hardened structures 
Organic Phase Separation  
Organic phase separation is just opposite of water phase 
separation technique. In this technique, the core is water 
miscible and the wall is hydrophobic in nature. In this, the 
water miscible material is enclosed in an oily solvent with a 
polymeric wall via addition of second polymeric material or 
non solvent. Polymeric concentration, temperature and 
amount of non solvent added will decide the quantity and 
state of polymer which is separated from the original 
solution. 
Organic Solvent Evaporation Technique (6) 
The solvent evaporation technique involves emulsification 
process in which oily phase contains a dispersed polymer 
and water phase contains excess amount of 
dissolved/dispersed drug. Shape and particles size of 
formulated emulsion is affected by concentration of 
emulsifier present in aqueous phase. When the emulsion is 
formed in desired droplet size, stirring rate in decreased and 
evaporation of organic solvent is done under reduced 
atmospheric pressure at an optimum temperature. This 
results in solid polymeric microspheres entrapping the drug. 
These solid microspheres   are   recovered   from   
suspension   by   different   methods   such   as filtration, 
centrifugation or lyophilization. This method is subdivided 
into two parts: 
 Single emulsion solvent evaporation 
 Multiple emulsion solvent evaporation 
Spray Drying 
Spray drying is generally applied in encapsulating sensitive 
subjects such as, essential oils, fragrances or vitamins. The 
solubility of drug in the polymer helps in deciding the 
internal structure of particles. Spray drying can be 
summarized as alteration of a feed from a liquefied condition 
such as dispersion, solution or paste, into a dehydrated 
particulate structure. This is done by inserting the feed into 
a hot gaseous drying medium as spray. It is a continuous one 
step processing operation in which four different phases are 
present. 
 Feed atomization 
 Spray and air mixing 
 Solvent evaporation 
 Separation of product 
Sometimes aggregation of proteins and peptides is observed 
in microspheres creating a critical problem during 
preparation of dosage form. Selection of solvent in 
microsphere preparation may play a role (7). Addition of 
additives in aqueous phase such as BSA (8). Sugars and PEG(9) 
have been studied in microspheres preparation. These 
additives are released along with drug from microspheres 
and affect the stability of microspheres adversely. 
To overcome the adverse effects of additives on releases rate 
of microspheres Kand et al. suggested a new method in with 
microspheres of human growth hormones were initially 
prepared with dextrin and then encapsulated in PLGA (10). 
This W/O/W method reduced initial burst and optimize the 
release rate of drug from microspheres(11).  
However various problems are still not resolved with these 
methods like wide size distribution and poor repeatability. 
Microspheres/Nanoparticles meant for parenteral use must 
be sterilized or prepared in aseptic environment and using 
sterile starting materials. The manufacturing process should 
also be checked continuously for safety of product (7). 
Normally used terminal sterilization methods should not be 
used with microspheres/Nanoparticles containing proteins; 
peptides as gamma radiation or heat sterilization may 
degrade them and adversely affects the efficacy of product  
(12). Similarly filtration cannot be used as sterilization 
method in case of microspheres as pore size of filter 
membrane is smaller than microspheres. Sterility testing 
should be as per pharmacopoeia standard for both external 
and internal aspects. The internal sterility is checked to 
verify the absence of microorganism inside the 
microspheres. 
Internal sterility testing may be performed using mixing of 
culture media with a solvent which can dissolve 
microsphere and liberate the inner content(13). Bacterial 
endotoxines may also be tested to check if endotoxins are 
well within the limits(14). 
Nath et al. used electro spraying method to prepare 
monodispersed particles containing PLGA in organic phase 
for preparation of simvastatin microspheres (15). This 
method enhances encapsulation efficacy and lowered wide 
range particle size distribution of microspheres. 
Recombinant human bone morphogenetic protein- 2 
(rhBMP-2) loaded microspheres of PLGA were prepared by 
Zang et al. using coaxial electrospraying(16). These 
microspheres were with narrow size distribution and during 
process of electro spraying there was no direct contact 
between drug and organic solvent. This process could 
protect drugs like proteins, genes and peptides which are 
unstable in organic solvent and lose their bioavailability. 
Uneven surface of these microspheres enhance cell adhesion 
and accelerates bone formation effect of drug. 
Residual solvent effect is always a critical problem in quality 
control of microspheres as PLGA/PLA are normally 
dissolved in organic solvent like methylenedichloride and 
ethyl acetate as oil phase. 
Supercritical carbon dioxide may be used as extracting agent 
to remove residual solvent from microspheres (17, 18). 
Recently near solvent free microspheres could be prepared 
with use of a new super critical emulsion extraction in a 
continuous process layout (19, 20). 
Emulsion solidification time is reduced by using a tower 
with counter current movement of emulsion and to improve 
encapsulation efficiency and reproducibility. This process is 
efficient for thermo labile drug due to mild operational 
temperature (21, 22). This process is also used for light 
sensitive micro/nano devices (23) Microspheres prepared by 
emulsification require mechanical stirrer to agitate two 
immiscible phases to reduce particle size of globules being 
easy process with low cost (24). However in the end the size 
separation of microspheres is done by sieving method which 
reduces the yield and increases the cost. To improve the 
yield of desired sized microspheres Liu et al. used glass 
beads of 4-6 mm diameter in continuous phase. These glass 
beads were able to enhance homogeneous dispersion though 
mechanical stirring (25). Through optimization of PLGA 
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concentration in solvent and with control of relative flow of 
aqueous and oil phase in mixing chamber Hung et al. 
prepared PLGA particles up to 70 nm(26). 
Uniform sized particles of PLGA may be prepared using 
premix membrane emulsification method with high yield. 
This method is able to produce microspheres of less than 8 
µm diameter (27). Using premix membrane emulsification 
method through control of pressure difference across the 
membrane and its pore size, Qi et al. successfully prepared 
uniform size (20 µm) microspheres of PLGA (28). Hot melt 
extrusion method is used for preparation of granules, 
sustained release tablets, pallets and other traditional 
dosage forms(29). In this process under optimized conditions 
drug and polymer mixture is extruded to prepare 
microspheres. PLGA/PLA microspheres are prepared by this 
method without using any organic solvent. As no organic 
solvent is evaporated from dosage forms hence no pores are 
developed during solidification and drug encapsulation is 
100% theoretically (30). Alorgan Inc. using hot extrusion 
method developed an implant containing dexamethasone 
with PLGA as intravitreal injection. The implant marketed 
with name as OZURDEX® for treatment of macular edema 
was approved by FDA in 2009(31). However this method 
cannot be used for thermo labile drugs as high temperatures 
are used in not melt extrusion method. Evonik®. Developed 
a method to prepare PLGA Microspheres named as 
FORMEZE.  A packed bed column was used in the method for 
emulsification. In this process dispersing phase passes in 
continuous phase through pores between beads of 50-
1000um filled in the column. Emulsion is repeatedly passed 
through column to reduce the globule size (32) to 10-100 um 
Controlled flow rate may be from 1 mL to 105 mL/min (29).  
Monodispersed PLGA/PLA microspheres or nano particles 
are prepared passing oil phase through the uniform pores of 
membrane into aqueous phase in membrane emulsification 
method to form uniform O/W emulsion. Liu et al. developed 
method to prepare w/o/w double emulsion using 
membrane emulsification method (33). They control the 
release rate of drug through size of microsphere by selecting 
proper pore size membrane (34). Method also provides higher 
drug entrapment efficiency in microspheres (35). A modified 
method of direct membrane emulsification known as 
rotating membrane emulsification has also been used to 
prepare uniform sized polymer microspheres (36). Liang et al. 
using rotating membrane emulsification method prepared 
PLGA microspheres of 100-1000 nm size. The prepared 
microspheres showed excellent therapeutic efficacy and 
good biosafety (37). Size of microspheres may be precisely 
controlled with narrow size distribution with the help of 
precision particle fabrication by combining microfluidic 
technology with solvent extraction (38). 
In this method equipment with double nozzle is used in 
which oil phase is forced through inner nozzle in cylindrical 
jet form and aqueous phase at a higher rate from external 
nozzle. Frictional forces between oil phase jet and 
continuous phase generates droplets. The force of pumping 
both phases controls the size of globules (39). 
LITERATURE REVIEW 
This review is focused on microspheres which have been 
prepared using synthetic and natural biocompatible 
polymers. Also, it highlights the studies which involve 
preparation of microspheres intended for parenteral usage. 
This review also covers summary of different methods used 
for the preparations of microspheres as well as olanzapine 
as it is chosen drug for proposed research work. 
One of the widely used biocompatible polymers is chitosan.  
Microspheres of chitosan were prepared with polyurethane 
by emulsification method for cardio vascular drugs such as 
isoxsuprine hydrochloride and calcium dobesilate. 
Characterization of microspheres were carried out using 
FTIR and XRD which showed uniform dispersion in polymer 
matrix.( 40) 
Chitosan has also been used to prepare microspheres of 
different drugs used for oral administration. Inter polymer 
complexes were prepared using chitosan and cellulose 
acetate phthalate (CAP) by emulsification-solvent 
evaporation method. These microspheres were used for oral 
delivery of an antimetabolite drug, 5-FU categorized as 
antineoplastic agent. Release time of 5FU was extended by 
12 hours using microsphere formulation.(41) 
Redox polymerization technique was also used to prepare of 
microsphere of chitosan. These microspheres were cross 
linked with glutaraldehyde and were used to  encapsulate  
enalapril  maleate  which  is  common  drug  for  the  
treatment  of hypertension.(42) 
Chitosan was also used to prepare mucoadhesive 
microspheres for gastro-retentive delivery of acyclovir. 
Along with chitosan other mucoadhesive polymers were also 
used such as thiolate chitosan, Methocal K15M and carbopol 
71G. These microspheres were prepared by emulsification-
cross linking method. (43) 
Small amount of chitosan blended in gelatin based 
microspheres showed prolong release of ceftiofour (44). 
Gelatin is another polymer used to prepare microspheres. 
Gelatin has been used to convey heparin-binding growth 
factors for wound healing purposes.(45) 
Carboxymethyl guar gum blended with gelatin resulted in 
microspheres which have semi-interpenetrating polymer 
network. These microspheres were prepared by 
emulsification method and was evaluated to determine 
controlled release of an antiasthamatic drug, 
theophylline(46). 
Gelatin microspheres of danofloxacin mesylate were 
prepared by emulsification-chemical cross linking 
technique.(47) Gentamycin loaded microspheres were 
prepared with b-tricalcium phosphate/gelatin for bone 
tissue engineering.  (48) 
Another polymer used to prepare microsphere is 
polycarbonate. It was used to encapsulate tetanus toxoid 
vaccine by modified emulsification-solvent evaporation 
technique (49). 
Bael fruit gum is also used to prepare microspheres of 5-FU 
by using as cross linking agent such as sodium trimeta 
phosphate in emulsification method. Encapsulating 5-FU 
was evaluated for anticancer efficacy against colon 
cancer(50). 
Poly(3-hydroxybutyrate) (PHB) is another polymer which 
was used in preparation of microspheres. The objective of 
these preparations was to study the controlled release 
characteristics of 6-mercaptopurine (51). 
Microsphere are also prepared by using eudragit L and S. 
Eudragit S and L were used to calculate the comparative 
input of microsphere and properties of drugs, specifically 
acid solubility, drug’s molecular weight and microsphere 
size. A chain of nine drugs with diverse physiochemical 
properties were effectively encapsulated in Eudragit L and 
Eudragit S microspheres using a new emulsion solvent 
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evaporation procedure. This method resulted in spherical 
microparticles with a constricted size allotment (27-60 and 
36-56 nm for Eudragit S and Eudragit L microspheres  
respectively)(52) 
Another polymer used is ethyl cellulose which produces void 
microspheres as a novel dosage form with increased 
stomach retention time. These microspheres were prepared 
by solvent evaporation-diffusion method to produce a 
suspended drug delivery system for ranitidine. (53) 
Most effective polymer being used today is PLGA. It has been 
used to prepare long acting injectable contraceptive. These 
PLGA microspheres provide contraceptive protection after 
one single injection for more than 3 months. 3 PLGA has 
been used to encapsulate leuprolide. (54) 
The quality parameters of naltrexone microspheres based on 
the copolymer of lactic and glycolic acids (PLGA) were 
established as a function of the microencapsulation process 
parameters. The release profile of the developed naltrexone 
dosage form  was  found  to  coincide  with  that  of  the  
reference  drug Vivitrol. The results were interesting 
scientifically and could be used to develop technology for 
producing generic Vivitrol.  (55) 
PLGA microspheres were used to characterize olanzapine on 
the foundation of in vitro behavior using dialysis. The goal of 
this formulation was to obtain an IVIV correlation(56). Depot 
formulations of olanzapine loaded PLGA microsphere were 
also prepared and characterized. Findings clearly indicated 
thatolanzapine PLGA microsphere can be used effectively to 
treat patients with varying mental conditions. (57) 
Keru Zhang et al. reviewed the structure and structure 
dependent applications of PLGA/PEG polymers specially 
concentrating on micelles and hydrogels. They also studied 
drug loading in PLGA/PEG micelles and reported its drug 
release profile (58). Farshad Ramzani et al. reported that for 
low molecular weight drugs microspheres are efficient 
controlled drug delivery systems. Emulsification with 
solvent extraction method reported to be with high 
encapsulation efficiency for hydrophobic small molecules. 
However Hydrophilic or amphiphilic small molecular may 
have low encapsulation as drug is partitioned between 
polymeric and external phase.(59) 
Tianshi Feng et al. Developed low density highly porous 
microspheres of PLGA for pulmonary drug delivery and 
studied synergistic release of paclitaxel and doxorubicin 
simultaneously in these microspheres (60).They found that 
for maximum therapeutic effects there should be higher 
ratio 5:1 of doxorubicin to paclitaxel. Release of paclitaxel 
and doxorubicin from double; layered microspheres, was 
reported in a similar study by Wei Li Lee et al. along with 
effects of loading two drugs in one single formulation and 
layer thickness on release rate. Microspheres prepared with 
PLGA having double layer loaded with two drugs subjected 
to drug release kinetics. Spheroids of MCF-7 cells were used 
to study the comparative anticancer effects of single layer 
and double layer microspheres with single drug and dual 
drug loading (61). It has been reported that implants of 
glucose biocensors have relatively short life as these are 
reacted as foreign body which is a major cause of 
dysfunction. But if coating of a biocompatible polymer is 
applied on implants the problem is resolved (62). Bing 
GuYanWang and Diane J. Burgess studied effect of PVA 
hydregel coating on release of dexamethasone form PLGA 
microspheres. They used mixture of low molecular 
weight(25 KDa) and high molecular weights (113 KDa) 
PLGA at different mass ratio to achieve long term drug 
release. It was concluded that use of polymer blend with 
PVA hydrogel coating enhances efficacy of biosensor up to 
4.5 months against foreign body reactions (63). During 
formulation of protein drugs in microspheres/ 
microencapsules wide distribution size and poor 
reproducibility has been observed along with deactivation of 
proteins, reducing efficacy of formulation. Sonication and 
mechanical stirring during common process may denature 
protein molecules. However use of member emulsification 
method has great advantages over conventional method of 
having uniform microspheres size and higher entrapment 
for drug. The release rate of drug can be controlled by 
optimizing thickness of coating of encapsulating material. 
Guang hui Ma in a study of preparation of microencapsule 
reported that use of protein drug powder instead of solution 
and using hydrophilic PELA as coating material with self 
solidification process prepared microencapsules were of 
uniform size and were able to maintain blood level of growth 
hormones (rhGH) for two months with single dose (64). 
Hao Wang et al. prepared chitosan microspheres loaded with 
docetaxel for lung targeted formulation. Microspheres were 
prepared using glutaraldehyde cross linking in water in oil 
emulsion. They found that this method is superior to 
conventional method in terms of uniform particle size 
distribution, morphological characters drug loading and in 
vitro release of drug (65) Imatinib loaded PLGA microsphere 
for sustain release were prepared by Nostrum et al. with 
high loading efficiency with sustain release of drug over a 
long period. Imatinib loaded PLGA microspheres were 
prepared by Nostrum et al. using dichloromethane as 
volatile solvent. Prepared microphese were of 6-20 µm size 
with smooth non porous surface using a double emulsion 
W/O/W method (66). Drug loading efficiency was found to be 
pH dependent (water phase). Microspheres were able to 
release drug for three months through diffusion of polymer 
matrix and erosion of polymer.  
Donepezil encapsulated microspheres were prepared by 
Wenjia Guo et al. for sustain release of drug for one week. 
PLGA was used for encapsulation material and solvent 
evaporation technique was used for the preparation of O/W 
emulsion(67) Microspheres with 30 µm mean diameter and 
15.92  0.31% drug loading efficiency were prepared. 
Differential scanning calorimetry and X ray diffraction 
revealed non porous surface and amorphous form of drug in 
the microspheres. Target oriented magnetic PLGA 
microspheres for chemotharmal therapy of cancer were 
prepared using doxorubicin as anticancer drug. Alternating 
current magnetic field was used to control the release of 
drug from microspheres having 28.3% Wt of Y-Fe2O2 (Ferric 
oxide). It was observed that drug release from ACMF 
exposed microspheres was seven times higher to that not 
exposed to magnetic field.(68) 
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